Cavallaro A, Piccolo G, Panebianco V, Menzo EL, Berretta M, Zanghì A, Vita MD, Cappellani A. Incidental gallbladder cancer during laparoscopic cholecystectomy: Managing an unexpected finding. World J Gastroenterol 2012; 18(30): 4019-4027 [PMID: 22912553 DOI: 10.3748/wjg.v18.i30.4019]
Corresponding Author of This Article
Dr. Andrea Cavallaro, MD, PhD, Department of Surgery, General Surgery and Breast Unit, University of Catania, Via S. Sofia 78, 95123 Catania, Italy. andreacavallaro@tiscali.it
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Andrea Cavallaro, Gaetano Piccolo, Antonio Zanghì, Maria Di Vita, Alessandro Cappellani, Department of Surgery, General Surgery and Breast Unit, University of Catania, Via S. Sofia 78, 95123 Catania, Italy
Vincenzo Panebianco, Department of Surgery, General Surgery Unit of Taormina Hospital “San Vincenzo”, 98039 Messina, Italy
Emanuele Lo Menzo, Division of Laparoscopic and Bariatric Surgery, University of Maryland, Baltimore, MD 21201, United States
Massimiliano Berretta, Department of Medical Oncology, National Cancer Institute - IRCCS, 33081 Aviano, Italy
ORCID number: $[AuthorORCIDs]
Author contributions: Cavallaro A, Piccolo G, Panebianco V and Cappellani A designed the study and collected the data; Cavallaro A, Piccolo G, Lo Menzo E and Cappellani A drafted the article; and all authors critically reviewed the article, read and approved the contents.
Correspondence to: Dr. Andrea Cavallaro, MD, PhD, Department of Surgery, General Surgery and Breast Unit, University of Catania, Via S. Sofia 78, 95123 Catania, Italy. andreacavallaro@tiscali.it
Telephone: +39-95-7179966 Fax: +39-95-3782912
Received: July 2, 2011 Revised: May 22, 2012 Accepted: May 26, 2012 Published online: August 14, 2012
Abstract
AIM: To evaluate the impact of incidental gallbladder cancer on surgical experience.
METHODS: Between 1998 and 2008 all cases of cholecystectomy at two divisions of general surgery, one university based and one at a public hospital, were retrospectively reviewed. Gallbladder pathology was diagnosed by history, physical examination, and laboratory and imaging studies [ultrasonography and computed tomography (CT)]. Patients with gallbladder cancer (GBC) were further analyzed for demographic data, and type of operation, surgical morbidity and mortality, histopathological classification, and survival. Incidental GBC was compared with suspected or preoperatively diagnosed GBC. The primary endpoint was disease-free survival (DFS). The secondary endpoint was the difference in DFS between patients previously treated with laparoscopic cholecystectomy and those who had oncological resection as first intervention.
RESULTS: Nineteen patients (11 women and eight men) were found to have GBC. The male to female ratio was 1:1.4 and the mean age was 68 years (range: 45-82 years). Preoperative diagnosis was made in 10 cases, and eight were diagnosed postoperatively. One was suspected intraoperatively and confirmed by frozen sections. The ratio between incidental and nonincidental cases was 9/19. The tumor node metastasis stage was: pTis (1), pT1a (2), pT1b (4), pT2 (6), pT3 (4), pT4 (2); five cases with stage Ia (T1 a-b); two with stage Ib (T2 N0); one with stage IIa (T3 N0); six with stage IIb (T1-T3 N1); two with stage III (T4 Nx Nx); and one with stage IV (Tx Nx Mx). Eighty-eight percent of the incidental cases were discovered at an early stage (≤ II). Preoperative diagnosis of the 19 patients with GBC was: GBC with liver invasion diagnosed by preoperative CT (nine cases), gallbladder abscess perforated into hepatic parenchyma and involving the transversal mesocolon and hepatic hilum (one case), porcelain gallbladder (one case), gallbladder adenoma (one case), and chronic cholelithiasis (eight cases). Every case, except one, with a T1b or more advanced invasion underwent IVb + V wedge liver resection and pericholedochic/hepatoduodenal lymphadenectomy. One patient with stage T1b GBC refused further surgery. Cases with Tis and T1a involvement were treated with cholecystectomy alone. One incidental case was diagnosed by intraoperative frozen section and treated with cholecystectomy alone. Six of the nine patients with incidental diagnosis reached 5-year DFS. One patient reached 38 mo survival despite a port-site recurrence 2 years after original surgery. Cases with non incidental diagnosis were more locally advanced and only two patients experienced 5-year DFS.
CONCLUSION: Laparoscopic cholecystectomy does not affect survival if implemented properly. Reoperation should have two objectives: R0 resection and clearance of the lymph nodes.
Citation: Cavallaro A, Piccolo G, Panebianco V, Menzo EL, Berretta M, Zanghì A, Vita MD, Cappellani A. Incidental gallbladder cancer during laparoscopic cholecystectomy: Managing an unexpected finding. World J Gastroenterol 2012; 18(30): 4019-4027
The widespread use of laparoscopic techniques has led to an increase in referrals for cholecystectomy. As a consequence, the incidental finding of gallbladder cancer (GBC) at an earlier stage has altered the management and the outcome of the disease. However, GBC remains a lethal disease associated with a dismal prognosis. Controversies exist on the optimal treatment of this unexpected finding during routine laparoscopic cholecystectomy. The management is difficult because no guidelines have been established and some authors have reported worse overall prognosis when the patient was not adequately treated during the first operation. If GBC is suspected preoperatively, open cholecystectomy must be performed to enable a complete evaluation of the disease extent and to allow radical resection, if necessary.
Simple cholecystectomy may be adequate treatment only for the earlier stages: Tis and T1a. Reoperation is recommended in cases of T2 tumors and more advanced stages of disease. On the contrary, controversies still exist on the need for more radical resection for T1b GBC. During reoperation it is also unclear what the appropriate extent of hepatic resection is, and whether hepatic resection can prevent liver recurrence.
We report our 10 years experience (19 cases) in the treatment of GBC, and we present a systematic review to evaluate the role of extended surgery in the treatment of the incidental GBC. A Medline search was performed using the keywords “Incidental gallbladder cancer”, “laparoscopic cholecystectomy”, “lymph nodes dissection” and “hepatic resection”.
Reviewing the literature, we focused on the following key points, which are still considered controversial in the management of GBC: (1) How laparoscopy has modified the presentation, the outcome, and the management of the patients with gallbladder cancer? (2) What is an appropriate extent of hepatic resection during reoperation, and can hepatic resection prevent liver recurrence? (3) What is the optimal extent of lymph node dissection? (4) When is resection of the common bile duct necessary? (5) Which type of surgical strategy should be used according to depth invasion? (6) Does laparoscopic cholecystectomy worsen prognosis? (7) Are port-site metastases a real problem? and (8) When is additional radical resection not indicated?
MATERIALS AND METHODS
Ethics
This work was carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association. All patients provided informed consent.
Data collection
From 1998 to 2008, in the Department of General Surgery of Catania University Hospital and in the General Surgery Unit of Taormina Hospital, 1490 patients underwent cholecystectomy. Within this group of patients, all the cases of GBC were retrospectively reviewed. Patients’ demographic data, as well as type of operation, surgical morbidity and mortality, histopathological classification, and survival data were collected in a database for further analysis. The diagnosis of gallbladder pathology was made by history, physical examination, and laboratory and imaging studies [ultrasonography and computed tomography (CT)].
Disease-free survival analysis
The patients were divided in two groups: incidental diagnosis of gallbladder carcinoma, and known or suspected diagnosis preoperatively. The primary endpoint of the study was disease-free survival (DFS) at different stages of diagnosis. The secondary endpoint was the difference in DFS between patients previously treated with laparoscopic cholecystectomy and patients who had oncological resection as their first intervention. The results are reported in percentages and means.
RESULTS
GBC was diagnosed in 19 patients, 11 women and eight men. The male to female ratio was 1:1.4 and the mean age was 68 years (range: 45-82 years).
According to tumor node metastasis staging of the 6th edition of the American Joint Committee on Cancer (AJCC), our patients were divided into: pTis (1), pT1a (2), pT1b (4), pT2 (6), pT3 (4), pT4 (2); five cases with stage Ia (T1 a-b); two with stage Ib (T2 N0); one with stage IIa (T3 N0); six with stage IIb (T1-T3 N1); two with stage III (T4 Nx Nx); and one with Stage IV (Tx Nx Mx). Eighty-eight percent of the incidental cases were discovered at an early stage (≤ II). A preoperative diagnosis was possible only in 10 cases; eight were diagnosed postoperatively during the pathological examination; and one was suspected intraoperatively and then confirmed by frozen sections. The ratio between incidental and nonincidental cases was 9/19, with eight cases discovered after laparoscopic cholecystectomy. The preoperative diagnosis of the 19 patients with GBC was: GBC with liver invasion diagnosed by preoperative CT (nine cases); gallbladder abscess perforated into hepatic parenchyma and involving the transversal mesocolon and hepatic hilum (one case); porcelain gallbladder (one case); gallbladder adenoma (one case); and chronic cholecystolithiasis (eight cases).
Pathological characteristics of the tumors were: one in situ cancer; three well-differentiated polypoid adenocarcinoma (G1); one well-differentiated nonpolypoid adenocarcinoma of the gallbladder fundus (G1); seven moderately differentiated polypoid adenocarcinoma (G2-G3); one moderately differentiated nonpolypoid adenocarcinoma (G2); and one and five polypoid and nonpolypoid poorly differentiated GBC (G3), respectively (Table 1).
Table 1 Patient characteristics with gallbladder cancer n (%).
IGBC
NIGBC
No. of patients (n = 19)
9
10
Polyposis lesions
7 (77.8)
5 (50)
Nonpolyposis lesions
1 (11.1)
5 (50)
Histopathological grade
G1
3 (33.3)
1 (10)
G2
6 (66.7)
3 (30)
G3
0
6 (60)
Lymphatic invasion
+
2 (22.2)
4 (40)
-
7 (77.8)
6 (60)
Vessel invasion
+
1 (11.1)
1 (10)
-
8 (88.9)
9 (90)
Perineural invasion
+
1 (11.1)
3 (30)
-
8 (88.9)
7 (70)
Stage
0
1 (11.1)
0
IA
4 (44.4)
2 (20)
IB
1 (11.1)
1 (10)
IIA
0
1 (10)
IIB
2 (22.2)
4 (40)
III
0
1 (10)
IV
1 (11.1)
1 (10)
Every case, except one, with a T1b or more advanced invasion underwent IVb + V wedge liver resection and pericholedochic/hepatoduodenal lymphadenectomy. One patient with stage T1b refused further surgery. Cases with Tis and T1a involvement were treated with cholecystectomy alone. One incidental case was diagnosed by intraoperative frozen section and treated with cholecystectomy alone. Six of the nine patients with incidental diagnosis reached 5-year DFS. Surprisingly, one patient reached 38 mo survival despite a port-site recurrence 2 years after the original surgery requiring further resection. Cases with nonincidental diagnosis were more locally advanced and only two patients experienced 5 years DFS (Tables 2 and 3).
How laparoscopy has modified presentation, outcome and management of patients with GBC
Presentation and outcome: The widespread use of laparoscopic cholecystectomy has led to discovery of this deadly disease at an earlier stage, altering the management and the outcome of these patients. GBC is an incidental finding in 0.25%-3% of patients and almost half of these cases are occasionally discovered during or after laparoscopic cholecystectomy for benign disease, such as gallstones and their complications (47% in the series of Memorial Sloan-Kettering Cancer Centre, 50% in the series of Johns Hopkins)[1,2]. The earlier discovery results in an earlier pathological stage, and consequently, increased long-term survival[2-4]. Patients with incidental GBC had a significant increase in survival when compared with those who had a preoperative diagnosis (overall 5-year survival 15% vs 33%)[2]. Therefore, the general surgeon should be prepared to deal with GBC suspected or diagnosed incidentally, following a well-established treatment algorithm[5-8]. It is paramount not to violate oncological principles during the first operation, if a two-stage approached is necessary. For this reason, the surgeon during video-laparoscopic cholecystectomy should always follow these simple rules: (1) perform a thorough preoperative diagnosis; (2) when in doubt, give up the laparoscopy to open access; (3) try to preserve the integrity of the gallbladder, handling it as little as possible; (4) close possible breaches of the wall with clips or endoloops; (5) always use the endobag for the removal of the gallbladder; (6) carefully inspect the gallbladder once extracted; (7) if in doubt, perform a histological examination impromptu; and (8) desufflate the pneumoperitoneum with the trocars in situ. During cholecystectomy, accidental opening of the gallbladder is described in 25%-30% of the cases, which clearly have a worse prognosis[3,9].
Management: The approach to incidental GBC is still controversial because of the difficulty of comparing data deriving from nonuniform case studies. Particularly discordant are the data deriving from western cancer registries with respect to the Japanese ones[3,4,10-13]. The only constant element seems to be that the prognosis strongly depends on the stage and on the possibility of achieving R0 oncological resection[3,4]. When incidental GBC is diagnosed afterwards by the pathologist, it is essential to restage the patients carefully by CT, magnetic resonance imaging and positron emission tomography, with a targeted study of the liver bed, peritoneum and of orifices of the trocars[14,15]. Moreover, a reassessment of the histological examination has to be performed, with a possible second opinion. This is important in order to: (1) confirm the pT; (2) specify the exact site of the tumor (hepatic side, bottom, infundibulum); (3) have a thorough evaluation of the cystic duct; and (4) evaluate whether the cystic lymph node is included in the histological examination. Today reoperation for incidental GBC should have two fundamental objectives: R0 resection of the liver parenchyma with the other adjacent structures, and clearance of the locoregional lymph nodes[7,8].
What is an appropriate extent of hepatic resection during reoperation and can hepatic resection prevent liver recurrence?
Hepatic resection for GBC must have two main aims: resect the tumor that has directly invaded the liver from the gallbladder bed, and prevent micrometastases that may recur around the gallbladder bed[3]. However, it remains unclear what an appropriate extent of hepatic resection is, and whether hepatic resection can prevent liver recurrence. Generally, operative procedures for incidental GBC include: extended cholecystectomy or Glenn resection (i.e., cholecystectomy plus partial resection of liver segments 4 and 5, approximately 2-3 cm from the gallbladder bed); anatomic resection of liver segment 5 and lower part of segment 4 when GC invades the liver bed to a depth of 2 cm or more; right hepatectomy when GC invaded the right Glisson capsule[3,7,8].
As noted in the literature, the preference today is for parenchyma-sparing operations, such as no anatomical wedge resection[1,3]. Araida et al[16] showed in a multicenter retrospective study, that there was no significant differences in survival and in recurrence rates of liver metastasis between patients that underwent resection of the gallbladder bed, anatomical segmentectomy 4b + 5 and hepatectomy for pT2 and pT3 GBC. He also proved that there were no particular preferences of recurrent liver metastasis for segment 4a + 5. Similarly, other authors have reported that there was no association between major hepatectomy and long-term survival, and that there was an increased association between major hepatic surgery and perioperative morbidity[1,3].
In order to support this, Pawlik et al[5] have proved that patients who had undergone major hepatic resection (anatomical segmentectomy of 4a + 5 or hemihepatectomy) had a similar risk of specific death as patients who underwent hepatic wedge resection, on both univariate and multivariate analyses. Rather than the type of hepatic resection, the most important factor that determines the final outcome is to obtain R0 resection. In fact, R1/R2 margin status is associated with decreased long-term survival[17].
In conclusion, for gallbladder cancer without hepatoduodenal ligament invasion and without any locoregional liver involvement, the wedge resection of the gallbladder bed (3 cm) is preferable to hepatectomy[3,5,17]. With regard to GBC that has invaded the gallbladder bed, in order to obtain negative histological margins, the preferred approach is nonanatomical resection of hepatic parenchyma, with a distal clearance of at least 2 cm[3,5,17].
Optimal extent of lymph node dissection?
In GBC, besides radical R0 resection, another main aim of surgery is to obtain complete clearance of the locoregional lymph nodes. GBC spreads through different pathways: direct locoregional invasion to lymphatic, vascular and neural invasion. The most common route of dissemination is lymphatic diffusion. This is facilitated by lymphatic channels in both the muscular and subserosal layers of the gallbladder. In addition, neoplastic cells, even without evident transmural invasion, often spread superficially to the other lymph nodes along the bile ducts[18-20]. The lymph nodes involved in the locoregional spread of GC can be divided into three: (1) cystic, pericholedochal and hilar lymph nodes; (2) lymph nodes around the portal vein, the common hepatic artery and periduodenal and peripancreatic lymph nodes; and (3) celiac, superior mesenteric artery and the para-aortic lymph nodes[18-20].
Although the cystic and pericholedochal lymph nodes are the first key station, the pathways of lymph node involvement from the first site of diffusion to the hepatoduodenal ligament (cystic, pericholedochal and hilar lymph nodes) tend to be highly variable[21]. In fact, GBC can spread directly to the third level of lymph nodes, along the perivascular soft tissue (celiac, superior mesenteric artery and the para-aortic lymph nodes), according to the three pathways of lymphatic drainage proposed by Ito et al[21]: cholecysto-retropancreatic pathway (main pathway), cholecysto-celiac and cholecysto-mesenteric pathways (accessory pathways). The incidence of occult lymphatic metastasis discovered during reoperation for incidental GBC can vary from 0% to 85% in relation to the depth of organ invasion (pT).
In fact, the reported incidence of occult lymphatic metastasis by stage is as follows: for T1a 0%-2.5%, for T1b 15%-25%, for T2 30%-50%, for T3 45%-75%, and for T4 > 85%[5,18,22-26] (Table 4). Similarly to other cancers, lymphadenectomy not only provides important staging information, but more importantly, may decrease the risk of locoregional recurrence. In fact, after tumor resection, the level of lymph node metastasis correlates with overall prognosis within the same pT stage category[25,26]. Miyakawa et al[27] reported 5-year survival of 60.3% for pN0 patients, 30.0% for pN1, 16.8% for pN2, and 5.9% for pN3. Hence, little controversy exists on the optimal management of T1a GBC. In fact, cholecystectomy alone is sufficient[3]. On the contrary, controversy still exists on the need for more radical resection in T1b GBC[24,26]. Moreover, different authors have advocated that not all T1b stages are the same, and treatment should be individualized. In fact, due to the strong correlation between lymphatic invasion and lymph node metastasis, Shibata et al[20] have advocated the use of lymphatic invasion as guidance for additional radical resection. However, this remains controversial because the absence of lymph node invasion does not exclude other recurrence such as liver metastases, peritoneal carcinomatosis or recurrence at the port sites, or expression of other forms of diffusion of GBC[28,29].
Table 4 Residual disease in the lymph nodes after re-resection for each pT (%).
Based on our review, we believe that resection of the gallbladder bed with regional lymph node dissection is the best choice for treatment of T1b GBC. In Western countries, lymphadenectomy is usually confined to the hepatoduodenal ligament around the hilar area (N1 lymph nodes: cystic, pericholedochal and hilar lymph nodes). Extended radical lymphadenectomy of N2 lymph nodes (including lymph nodes around the portal vein, common hepatic artery, and periduodenal and peripancreatic lymph nodes) is not routinely advocated[3,4]. Currently, according to the 7th edition of AJCC staging, N2 involvement is considered as M1 metastasis, and represent a potential contraindication to additional radical surgery[30].
When is resection of the common bile duct necessary?
Resection of the common bile duct performed at the time of the hepatic resection and lymphadenectomy is controversial[31-33]. GC has a strong tendency to invade the hepatoduodenal ligament in the form of perineural invasion or lymph node metastasis, therefore, en bloc resection of the regional lymph nodes together with excision of the connective tissue around the portal and hepatic artery should be performed, whenever lymph node dissection of the hepaduodenal ligament is entertained[34-36]. Dissection of the hepatoduodenal ligament implies a risk of inducing ischemic damage to the common bile duct, therefore, Shimizu et al[10] proposed routine resection of the extrahepatic bile duct to facilitate lymphadenectomy, avoiding common bile duct ischemia, and increasing the number of lymph nodes harvested. However, these benefits have not been confirmed in other studies[32,33]. Pawlik et al[5] showed that the median number of lymph nodes harvested at the time of lymphadenectomy was the same (n = 3), regardless of whether the common bile duct was or was not resected concomitantly with lymph node dissection (P = 0.35). Araida et al[31]
found that, in patients with advanced GBC, who did not have direct invasion of the hepatoduodenal ligament and/or of the cystic duct, bile duct resection did not result in any differences in terms of recurrence and overall survival, but it only exposes patients to the potential complications of the bilioenteric anastomosis.
In conclusion, bile duct resection should be performed only when the patients have a positive involvement of the cystic duct margins, discovered either on the pathological review of the initial cholecystectomy or through biopsy of the cystic duct at the time of the second operation[3,32,33]. In fact, microscopic involvement of the cystic duct margin is associated with a residual and/or additional disease in the common bile duct in over one-third of the cases[32,33].
Type of treatment according to depth invasion
Contrary to other gastrointestinal carcinomas, the depth of invasion of GBC dictates the extent of surgical resection. In cases of carcinoma in situ or tumor invading the mucosa (Tis and T1a), simple cholecystectomy with negative surgical margins can be considered as curative surgery[3,4,23,37].
The 5-year survival after simple cholecystectomy is between 99% and 100%[23,37]. When the muscularis layer is involved (T1b), a 20%-50% local-regional recurrence can be expected after simple cholecystectomy[3,6,37] (Table 5). At the time of reoperation, it has been shown that there is a 10% incidence of residual disease in the liver bed associated with a 15%-25% incidence of residual metastatic lymph node involvement[22,24,26]. The 5-year survival after simple cholecystectomy is between 40% and 50%[6,23,36-39]. Therefore, the recommended procedure is cholecystectomy associated with resection of at least 3 cm of liver parenchyma (wedge resection), plus adequate lymphadenectomy (Glenn’s resection)[37-39]. When the tumor extends beyond the serosa and invades the liver or an organ or an adjacent structure (T3), there is a 36% incidence of residual disease at the liver level and 45%-75% incidence of lymph node dissemination[5,22,25,26]. The goal of surgical intervention is to obtain R0 resection, hence, mandatory steps include extended lymphadenectomy and extended hepatic resection, associated with resection of other organs and structures, when necessary[35]. T3 patients are at high risk of peritoneal metastases, therefore, explorative laparoscopy should be considered in order to avoid unnecessary laparotomy. The 5-year survival after simple cholecystectomy is 0%-15%, and reaches 25%-65% after extended resection[5,23,36] (Table 5).
Table 5 Five-year survival according to both stage of gallbladder cancer and type of surgery (%).
Does laparoscopic cholecystectomy worsen prognosis?
More cases of GBC are incidentally diagnosed during laparoscopic cholecystectomy, thus, the question arises whether laparoscopic cholecystectomy worsens the prognosis of these patients. Drouard et al[40] first described the development of port-site metastases in 1991, and additional proof came in 1994[41]. This contributed to the loss of interest in approaching malignancy laparoscopically. Furthermore, excessive manipulation of the organ and perforation can cause intraperitoneal spread of malignant cells, resulting in a worse long-term survival[42]. In fact, the incidence of port-site recurrence increased from 9% in patients without intraoperative perforation to 40% in those in whom perforation could be demonstrated[43]. Other studies proved that pneumoperitoneum significantly increased tumor cell implantation at trocar sites, and tumor growth in the peritoneum[44-46]. However, laparoscopic cholecystectomy, if correctly performed, did not influence the long-term prognosis of early stage tumors (T1a, T1b, T2)[7,8]. Also, radical re-resection, performed several months after laparoscopic cholecystectomy, has similar results to radical resection in one stage, and long-term survival can be achieved in tumors with infiltration of the liver in patients who have previously undergone noncurative surgery[1,7,8,23]. Survival is strictly related to the depth of parietal invasion of the tumor, but there is no significant difference between patients with incidental GBC discovered during or after cholecystectomy (P = 0235)[7]. The real problem is to have a clear understanding of how to deal with this eventuality.
Are port-site metastasis a real problem?
Port-site metastasis is the most common form of parietal recurrence (Table 6). It has been reported at all stages of gallbladder carcinoma and at any of the trocar sites. It generally presents after latency, ranging from a few months to 3-4 years. Many factors can contribute to port-site metastasis. One of the most important is intraoperative spillage of bile from gallbladder wall perforation, which has been described in 30% of laparoscopic cholecystectomy cases, and it has been linked to port-site metastasis[43,44,47,48]. Intraoperative manipulation of the tumor, in the form of tension, dissection and isolation, often leads to the disintegration of a certain proportion of cancer cells, as confirmed by the presence of granular cells in 40% of laparoscopic instruments[49,50]. The increased intraperitoneal pressure induced by the CO2 pneumoperitoneum can spread and redistribute cancer cells within the peritoneal cavity and in damaged surfaces. Finally, evidence exists on the immunosuppressive action of CO2 which would favor the implantation of tumor cells[50]. The median survival after port-site metastasis is approximately 1 year, and it is mandatory to perform resection at the time of reintervention in patients previously treated with laparoscopic cholecystectomy[3,7,8].
Table 6 Metastasis at port-site and at subcostal laparotomy (%).
With the primary goal of surgery in mind (R0 resection), the only contraindication to additional surgery is the inability to obtain radical R0 resection. In particular, the presence of peritoneal metastasis, distant metastasis, locally advanced GBC with N2 or M1 (according to the 7th edition of AJCC staging), lymph node invasion along the hepatic artery, portal vein and celiac and mesenteric vessels are all considered contraindications to radical resection[35,51-53]. On the other hand, the presence of peripancreatic (head only) lymph node disease is not a contraindication to surgical excision, and radical lymphadenectomy and pancreaticoduodenectomy can be carried out together with liver resection[35,53]. Also, the depth of liver involvement and multiorgan locoregional involvement do not represent a contraindication for additional radical resection[51,52]. Combined pancreaticoduodenectomy, right hemicolectomy and major hepatectomy are effective treatment for GBC with direct invasion of the adjacent organs (stomach, duodenum, pancreas, colon and liver), but only if potentially curative resection (R0) is feasible. In these cases of multiorgan resection for GBC, given radical R0 resection, the long-term survival will depend on bile duct involvement[35,51-53]. In fact, stromal invasion of the extrahepatic bile ducts is sometimes a prelude to hepatoduodenal ligament involvement, and is also associated with a higher rate of metastases to para-aortic nodes with a high incidence of residual tumor and poor outcome after surgery[32].
In conclusion, incidental carcinoma of the gallbladder, as our experience confirms, generally is diagnosed at an earlier stage and carries a better prognosis than nonincidentally found cancer. Laparoscopic cholecystectomy does not affect survival if implemented with proper technique. Simple cholecystectomy may be an adequate treatment only for earlier stage GBC: Tis and T1a. All other stages, starting from T1b should be treated with lymphadenectomy and resection of at least 2-3 cm of liver parenchyma around the liver bed, provided that no residual microscopic cancer (R0) remains. Resection of the main bile ducts could be necessary in hilum-type cancers with positive margins of the cystic duct. More extensive liver resection or performance of multiorgan resection can be pursued in order to achieve R0 resection.
COMMENTS
Background
Gallbladder carcinoma remains a rare, but highly aggressive disease. Its dismal prognosis is associated with the advanced stage of the disease at the time of diagnosis.
Research frontiers
Controversy exists about the optimal management of the disease. In particular, the debate involves the extent of surgical resection of the liver and surrounding organs, the need for resection of the main bile duct, the extent of lymph node removal, and the potential for negative effects of previous laparoscopic cholecystectomy. It is also unclear when surgery is not indicated at all.
Innovations and breakthroughs
Previous studies have proved how simple cholecystectomy is sufficient treatment for early stages of gallbladder carcinoma. Also, it seems that, at more advanced stages, it is paramount to obtain complete gross oncological resection (R0) without the need for anatomical hepatic resection. In order to minimize port-site metastasis, the laparoscopic approach to apparently benign gallbladder disease has to follow specific principles: minimal manipulation of the gallbladder; avoidance of rupture of the gallbladder and bile spillage; extraction of the specimen with a protective bag to avoid contact with the skin; and evacuation of the intraperitonealy insufflated gas via the cannulae.
Applications
The authors conclude that gallbladder cancer can be adequately cured when the diagnosis is early and the treatment is standardized by stage. Incidental carcinoma of the gallbladder is generally diagnosed at an earlier stage and carries a better prognosis than nonincidentally found cancer. Laparoscopic cholecystectomy does not affect survival if implemented with proper technique. Simple cholecystectomy may be adequate treatment only for the earlier stages. All other stages should be treated with lymphadenectomy and resection of at least 2-3 cm of liver parenchyma around the liver bed, provided that no residual microscopic cancer remains. Resection of the main bile ducts could be necessary in cancers with positive margins of the cystic duct. More extensive liver resection or performance of multiorgan resection can be pursued in order to achieve complete resection of the tumor. This research can certainly guide surgeons that encounter this rare entity unexpectedly. In fact, as long as the appropriate referrals are made, the prognosis does not worsen. This can also increase awareness of this rare, but potentially lethal disease.
Terminology
R0 is the surgical removal of all the grossly apparent tumor cells. Port-site metastasis refers to implantation of tumor cells at the skin incisions utilized to place the laparoscopic trocars.
Peer review
The authors present solid experience with a rare disease. Their clinical analysis, along with a thorough review of the literature, provides a clear algorithm to approach the disease at different stages.
Footnotes
Peer reviewer: Yasuji Arase, MD, Department of Gastro-enterology, Toranomon Hospital, 2-2-2 Toranomonminato-ku, Tokyo 105-8470, Japan
de Aretxabala XA, Roa IS, Mora JP, Orellana JJ, Riedeman JP, Burgos LA, Silva VP, Cuadra AJ, Wanebo HJ. Laparoscopic cholecystectomy: its effect on the prognosis of patients with gallbladder cancer.World J Surg. 2004;28:544-547.
[PubMed] [DOI][Cited in This Article: ]
Tsukada K, Kurosaki I, Uchida K, Shirai Y, Oohashi Y, Yokoyama N, Watanabe H, Hatakeyama K. Lymph node spread from carcinoma of the gallbladder.Cancer. 1997;80:661-667.
[PubMed] [DOI][Cited in This Article: ]
Shibata K, Uchida H, Iwaki K, Kai S, Ohta M, Kitano S. Lymphatic invasion: an important prognostic factor for stages T1b-T3 gallbladder cancer and an indication for additional radical resection of incidental gallbladder cancer.World J Surg. 2009;33:1035-1041.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 29][Cited by in F6Publishing: 31][Article Influence: 2.1][Reference Citation Analysis (0)]
Liang JW, Dong SX, Zhou ZX, Tian YT, Zhao DB, Wang CF, Zhao P. Surgical management for carcinoma of the gallbladder: a single-institution experience in 25 years.Chin Med J (Engl). 2008;121:1900-1905.
[PubMed] [DOI][Cited in This Article: ]
Jensen EH, Abraham A, Jarosek S, Habermann EB, Al-Refaie WB, Vickers SA, Virnig BA, Tuttle TM. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer.Surgery. 2009;146:706-711; discussion 711-713.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 67][Cited by in F6Publishing: 72][Article Influence: 4.8][Reference Citation Analysis (0)]
Araida T, Higuchi R, Hamano M, Kodera Y, Takeshita N, Ota T, Yoshikawa T, Yamamoto M, Takasaki K. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study.Surg Today. 2009;39:770-779.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 47][Cited by in F6Publishing: 41][Article Influence: 2.7][Reference Citation Analysis (0)]
Drouard F, Delamarre J, Capron JP. Cutaneous seeding of gallbladder cancer after laparoscopic cholecystectomy.N Engl J Med. 1991;325:1316.
[PubMed] [DOI][Cited in This Article: ]
Xiao WD, Peng CH, Zhou GW, Wu WD, Shen BY, Yan JQ, Yang WP, Li HW. Surgical treatment for Nevin stage IV and V gallbladder carcinoma: report of 70 cases.Hepatobiliary Pancreat Dis Int. 2005;4:589-592.
[PubMed] [DOI][Cited in This Article: ]
Shirai Y, Ohtani T, Tsukada K, Hatakeyama K. Combined pancreaticoduodenectomy and hepatectomy for patients with locally advanced gallbladder carcinoma: long term results.Cancer. 1997;80:1904-1909.
[PubMed] [DOI][Cited in This Article: ]
